By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TaiGen Biotechnology 

Nei-Hu  Taipei    Taiwan
Phone: N/A Fax:



Start Up

Company News
TaiGen Biotechnology Starts China Trial Of Novel Chemotherapy Sensitizer 5/1/2015 11:09:40 AM
TaiGen Biotechnology Announces Initiation of Burixafor Chemosensitization Clinical Trial In Acute Myeloid Leukemia In China 4/30/2015 6:21:40 AM
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015 6:39:31 AM
ScinoPharm To Provide Active Pharmaceutical Ingredient To TaiGen Biotechnology For Novel Stem Cell Drug 6/9/2014 10:17:55 AM
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014 11:05:33 AM
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014 1:44:50 PM
TaiGen Biotechnology Signed Exclusive License Agreement With R-Pharm For Nemonoxacin (Taigexyn®) 1/15/2014 8:00:55 AM
TaiGen Biotechnology Expects China Launch Of Novel Antibiotic In 2014 1/6/2014 11:23:29 AM
TaiGen Biotechnology Receives Qualified Infectious Disease Product And Fast Track Designations From The FDA For Nemonoxacin (Taigexyn®) 12/23/2013 9:04:17 AM
TaiGen Biotechnology Reports Phase IIa Data for TG-0054 at the 2013 American Society of Hematology Annual Meeting 10/30/2013 6:55:02 AM